It is crucial to better understand, diagnose, and manage this skin condition associated with significant quality-of-life impairment.
Understanding the difference in biology and clinical presentations of cutaneous conditions in different skin types is critical for health care professionals to treat a diverse population.
Graber discusses isotretinoin dosing and monitoring pearls at SCALE 2023.
Sonya Kenkare, MD, explains her approach to itch and the support system of multiple specialties to help a pediatric patient with atopic dermatitis.
Frequent fliers, including pilots and cabin crew, are exposed to greater levels of UV and cosmic ionizing radiation than the general population, leading to higher incidence of skin cancers.
In the final part of this Frontline Forum series, Brent Moody, MD; Sarah Arron, MD, PhD; Justine Cohen, DO; Emily Ruiz, MD, MPH; and Todd Schlesinger, MD, review 4 real-world clinical cases of BCC and the treatments they utilized.
Second-line end points of the TRICOTEL trial assessing atezolizumab plus vemurafenib and cobimetinib in melanoma with central nervous system metastases appear consistent with primary efficacy end points.
A variety of topicals and biologics are now available to treat children affected by this challenging condition.
It is important for pediatric and family nurse practitioners caring for patients with dermatological conditions to be comfortable talking about the conditions with children, adolescents, and their parents.
This expert review explores the multifaceted causes of female hair loss—hormonal imbalances, inflammation, nutrient deficiencies, aging, and oxidative stress—and explores non-pharmaceutical interventions.
Frequent fliers, including pilots and cabin crew, are exposed to greater levels of UV and cosmic ionizing radiation than the general population, leading to higher incidence of skin cancers.
Smidt and Hunt offer insights on navigating pediatric dermatology decision-making, emphasizing learning from clinical scenarios and fostering a culture of feedback and improvement.
Dr. Matt Davidson, Ph.D., wanted to find an effective and affortable treatment for the recurring common warts on his hands, which has lead him to become one of the youngest, if not youngest, pharmaceutical company pioneers in the country.
In this quiz, Kaivon Sobhani, B.S., and, Eve Lowenstein, M.D., Ph.D., FAAD, address dermatofibrosarcoma protuberans (DFSP), keloids, hypertrophic scars and dermatofibromas.
Research has begun to explore natural compounds that address the oxidative stress, autoimmunity, and altered melanogenesis that drive vitiligo pathogenesis.
La Roche-Posay is developing a nail art version of My UV Patch with clinical trials to start this year.
Learn about the evolution of aesthetic lasers from their theoretical origins to the advanced medical devices we have today.
Rare aggressive cutaneous lymphoma puts patients at risk of thyroid and non-lymphocytic leukemia second primary malignancies, researchers say.
Topical sirolimus may provide a less-invasive treatment option for patients with angiofibroma, according to recent studies.
Efforts are underway to identify new therapeutic methods that can offer improved outcomes for patients with hidradenitis suppurativa.
Traditional treatments remain important parts of the dermatologist's armamentarium for acne management, but other drugs have begun to play a role, too. Meanwhile, research is offering new insight into the causes of acne. Stay up to date on the latest insight into acne's pathogenesis, evaluation and treatment. Participate in this forum.
In this article, Drs. Lawrence Eichenfield and Jessica Sprague review some of the most significant findings and developments in pediatric dermatology from the last year beginning with the availability of biologic agents for pediatric psoriasis and atopic dermatitis.
The need for clear images of cutaneous conditions is more critical in dermatology than perhaps any other specialty. In this article, we feature the photography of Dr. Justin Finch who leads the clinical photography program in dermatology at the University of Connecticut Health Center in Farmington, Conn. Dr. Finch shares his photography tips in this “How To” guide.
Dr. Day presents her best tips on approaching social media channels as a tool to engage with potential patients, knowing your audience and sharing the latest science and trends in dermatology.
In this installment of our melanoma case studies series, we focus on common cancers in unusual locations versus uncommon cancers in classic locations.